Ray Dalio's TDOC Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 11,740 shares of Teladoc Health, Inc. (TDOC) worth $63,983, representing 0.00% of the portfolio. First purchased in 2020-Q4, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in TDOC, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 473,309 shares. Largest reduction occurred in Q1 2026, reducing 622,739 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Teladoc Health (TDOC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teladoc Health (TDOC) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -622,739 | Reduce 98.15% | 11,740 | $5.45 |
| Q4 2025 | +150,730 | Add 31.16% | 634,479 | $7.00 |
| Q3 2025 | +473,309 | Add 4533.61% | 483,749 | $7.73 |
| Q2 2025 | -2,358 | Reduce 18.42% | 10,440 | $8.71 |
| Q1 2025 | -16,078 | Reduce 55.68% | 12,798 | $7.96 |
| Q4 2024 | -83,930 | Reduce 74.40% | 28,876 | $9.09 |
| Q3 2024 | -123,580 | Reduce 52.28% | 112,806 | $9.18 |
| Q2 2024 | -38,190 | Reduce 13.91% | 236,386 | $9.78 |
| Q1 2024 | -37,273 | Reduce 11.95% | 274,576 | $15.10 |
| Q4 2023 | -35,721 | Reduce 10.28% | 311,849 | $21.55 |
| Q3 2023 | +26,070 | Add 8.11% | 347,570 | $18.59 |
| Q2 2023 | +9,657 | Add 3.10% | 321,500 | $25.32 |
| Q1 2023 | -12,453 | Reduce 3.84% | 311,843 | $25.90 |
| Q4 2022 | -89,204 | Reduce 21.57% | 324,296 | $23.65 |
| Q3 2022 | -9,331 | Reduce 2.21% | 413,500 | $25.35 |
| Q2 2022 | +24,509 | Add 6.15% | 422,831 | $33.21 |
| Q1 2022 | +96,930 | Add 32.16% | 398,322 | $72.13 |
| Q4 2021 | +31,202 | Add 11.55% | 301,392 | $91.82 |
| Q3 2021 | -8,368 | Reduce 3.00% | 270,190 | $126.81 |
| Q2 2021 | +268,383 | Add 2637.67% | 278,558 | $166.29 |
| Q1 2021 | -18,142 | Reduce 64.07% | 10,175 | $181.72 |
| Q4 2020 | +28,317 | New Buy | 28,317 | $199.95 |
Ray Dalio's Teladoc Health Investment FAQs
Ray Dalio first purchased Teladoc Health, Inc. (TDOC) in Q4 2020, acquiring 28,317 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Teladoc Health, Inc. (TDOC) for 22 quarters since Q4 2020.
Ray Dalio's largest addition to Teladoc Health, Inc. (TDOC) was in Q3 2025, adding 483,749 shares worth $3.74 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 11,740 shares of Teladoc Health, Inc. (TDOC), valued at approximately $63,983.
As of the Q1 2026 filing, Teladoc Health, Inc. (TDOC) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Teladoc Health, Inc. (TDOC) was 634,479 shares, as reported at the end of Q4 2025.